Vimarsana
Biggest News Aggregation in the World

Page 28 - Outlayer Item News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outlayer Item Today - Breaking & Trending Today

Addition of darolutamide to ADT, docetaxel prolongs OS in metastatic prostate cancer - Vimarsana News

Addition of darolutamide to ADT, docetaxel prolongs OS in metastatic prostate cancer

SAN FRANCISCO — The addition of darolutamide to androgen deprivation therapy and docetaxel prolonged OS among men with metastatic hormone-sensitive prostate cancer, according to study results presented at ASCO Genitourinary Cancers Symposium. The regimen reduced risk for death by 32.5%.

Source: healio.com
Mental disorders generally lower in immigrant/refugee vs. nonimmigrant youths - Vimarsana News

Mental disorders generally lower in immigrant/refugee vs. nonimmigrant youths

Prevalence of mental disorders among first- and second-generation immigrant and refugee children and youth was generally lower relative to similar populations of nonimmigrants, per a Canadian cohort study published in JAMA Network Open.“For at least half of all mental health problems across the life course, onset is in childhood or adolescence. Understanding mental disorder prevalence prior

Source: healio.com
Acadia resubmits sNDA for pimavanserin for Alzheimer's disease psychosis - Vimarsana News

Acadia resubmits sNDA for pimavanserin for Alzheimer's disease psychosis

Acadia Pharmaceuticals Inc. has resubmitted its supplemental new drug application to the FDA for pimavanserin for treating hallucinations and delusions linked to Alzheimer’s disease psychosis. The resubmission came as a response to the FDA’s complete response letter in April 2021 to the initial sNDA for a proposed indication for pimavanserin for treating dementia-related psychosis.

Source: healio.com
IV vedolizumab effectively treats chronic pouchitis in UC - Vimarsana News

IV vedolizumab effectively treats chronic pouchitis in UC

Among patients with ulcerative colitis, IV vedolizumab safely and effectively treated chronic pouchitis following ileal pouch-anal anastomosis, according to research presented at the Congress of European Crohn’s and Colitis Organization.

Source: healio.com
Cardiovascular risk factors prevalent among patients with triple-negative breast cancer - Vimarsana News

Cardiovascular risk factors prevalent among patients with triple-negative breast cancer

Patients with triple-negative breast cancer have a high prevalence of cardiovascular risk factors that increase their risk for noncancer morbidity and mortality, according to study results.Younger Black women with triple-negative disease had a higher likelihood of having hypertension and obesity — both of which could put them at higher risk for cardiotoxicity from chemotherapy, according to

Source: healio.com